It’s official. Moving to UT San Antonio to lead their GU program. Also looking to recruit new GU medical oncologists—message me if interested to join a growing program. Great urologic oncology presence and history. Now let’s also make med onc history there together
Benjamin L Maughan
1,340 posts
I am a physician specializing in the treatment of genitourinary cancers. I am passionate for improving cancer therapy through research.
Salt Lake City, UT
Joined February 2017
- We are in business! It has been a few years of working through the process of opening. Thanks for the feedback from everyone in the GU community. Looking forward to testing IO therapy for PRCC in a randomized trial--a novel aspect of this trial and #SAMETA
- Please see our TIP for S2200 (PAPMET2). Randomized study for mPRCC. Important—in my opinion—to test combination vs sequential tx in pts with the heterogenous dz PRCC. @SWOG @montypal @PBarataMD @DrVaishampayan @KidneyCancerDoc
- In Phoenix for @ASCO Direct meeting. Get to do two if my favorite things: talk about prostate cancer and go running! I even found a cactus!!
- I am humbled to be included with these passionate scientists @huntsmancancer this is really a special place to work! Twitter world, this is an open invitation to visit us!!
- FDA published PARPi results by biomarker. Largest to date — confirming prior data that ATM and CHEK2 have poor response. High number for BRCA, CDK12, PALB2 adds confidence for good ORR + PFS ascopubs.org/doi/abs/10.120…
- Love working with this guy—so kind and brilliant! He helps bring so many clinically meaningful #clinicaltrials @huntsmancancer for our patients! COSMIC-021 is a perfect example!.@neerajaiims of @huntsmancancer discusses the drug synergy of chemo + IO for mCRPC found in the COSMIC-021 Study. Abs # 139 👉 fal.cn/36xzW #GU20 #pcsm
00:00 - The final session of #GU24 ended with a bang! check out the great talks and discussion from @BraunMDPhD Sophia Kamran and @KidneyCancerDoc and co-chaired by the effusive @ZakhariaYousef perfect platform to get the mental juices flowing for developing new IIT ideas!
- I have been reading these seminal @NEJM papers for years that report practice changing research. Humbling to have participated in this effort. Grateful for all of the support I receive @huntsmancancer @NeliMUlrichJust in @NEJM 👉HIF-2α inhibitor Belzutifan 120 mg QD PO leads to 49% ORR in pts with #kidneycancer associated with VHL disease. Open acccess👉bit.ly/3l8Y48J Congrats @EJonasch & team Very proud to see @maughanonc @huntsmancancer @Huntsman_GU 👇 @OncoAlert @NeliMUlrich
- Come by right now in the poster session to see the work presented my our prodigious fellow. Studying genomic alteration in typical vs neuroendocrine prostate cancer. Thanks @ASCO for the merit award—great honor for his ongoing research!! @ggebraelmd @neerajaiims @umangtalking
- Lots of time to think while doing my personal 🦃 Trot in the Rocky Mtn foothills. Grateful for many ppl and experiences that help me have hope for a meaningful and love filled future. Wishing the same for all those unfortunately touched by cancer.
- On vacation so running with my kiddo! Now I finally have a location that can rival the daily pics of @DrRanaMcKay
- Can’t emphasize enough how this work has transformed my perspective when I see pts in clinic. I definitely am in the group that under appreciated the frequency of this issue. Thx for helping me better understand the patient perspective.#GU35 44% of #kidneycancer pts spend HOURS thinking about cancer. In last 90 days, 36% have gone to ER. >1/3 of patients say that cancer always/often impacts their ability to eat, sleep and engage with family and friends. Surviving is not the same as living. #diseaseburdenzero























